Release Date: 26/11/12 14:29 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 1.45MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%